Cosentyx goes head to head against Humira in psoriatic arthritis…it’s mostly a draw

Two biologics that work on psoriatic disease differently – Cosentyx (drug name secukinumab, an IL-17a inhibitor) and Humira (drug name adalimumab, a TNF-alpha inhibitor) – were recently tested in a…

Company behind Humira and Skyrizi asks regulators to green-light Rinvoq for psoriatic arthritis

…for psoriatic arthritis, where it is performing well. Skyrizi actually bested Humira in clearing psoriasis it its own clinical trial head-to-head sponsored by AbbVie. With biosimilar versions of Humira being…

AbbVie, maker of Humira and Skyrizi, getting closer to third product to fight psoriatic disease

…psoriasis clinical trial head-to-head against its own blockbuster, Humira, where Skyrizi came out on top. That’s good news for psoriasis patients, but also for AbbVie shareholders, since Humira’s patents are…

Psoriasis & Psoriatic Arthritis Treatment Options

…another treatment within the same class of biologic can be a successful treatment strategy. Humira has also shown success treating psoriasis of the hands and feet. Humira is self-injected under…

Do I need to worry about links between psoriasis and Alzheimer’s disease?

…were acitretin (used commonly as a treatment in South Korea), methotrexate, cyclosporine, and biologic agents (like Enbrel, Humira, etc.). Here are the key findings: As compared to people without psoriasis,…

What is ALZUMAb? It’s the psoriasis biologic no one in America has heard of

Ever heard of Enbrel? Humira? How about ALZUMAb? ALZUMAb (drug name itolizumab) is a “humanized anti-CD6 monoclonal antibody” for adults with active moderate to severe psoriasis. It has a different…

The Latest Psoriasis News

Company behind Humira and Skyrizi asks regulators to green-light Rinvoq for psoriatic arthritis

AbbVie, the North Chicago company behind the longtime blockbuster biologic Humira (adalimumab) and the new biologic Skyrizi (risankizumab-rzaa), has asked the U.S. Food and Drug Administration (FDA) and its European counterpart to approve its rheumatoid arthritis (RA) drug Rinvoq (upadacitinib) for psoriatic arthritis. Rinvoq is a JAK inhibitor administered as Continue Reading…

Our new “Psoriasis Journey” campaign is rolling out

Our new Psoriasis Journey campaign is rolling out now to prep for for an official June 8, 2020 launch. On that date, our volunteer patient with severe psoriasis is going to begin one of the cutting-edge psoriasis treatments we’ve been hearing so much about. You can follow along with his Continue Reading…

Want to try an experimental psoriasis treatment for your skin or scalp?

Before a doctor can prescribe a treatment, it goes through years of research and testing, including multiple rounds of clinical trials, using volunteer patients to test a potential treatment’s safety and effectiveness. The clinical trials are developed in consultation with government regulators (here, the US Food and Drug Administration, or Continue Reading…